Clinical Laserthermia Systems AB resolves on a directed issue

Clinical Laserthermia Systems AB (publ), a company focused on clinical laser therapy, has decided through its board of directors to implement a directed share issue. However, the company's announcement does not provide specific details regarding the size of the issue, the subscription price, or the targeted investors.

The primary goal of the share issue is to strengthen the company's financial position and support its future business development initiatives. The company aims to raise capital to continue its product development and market expansion efforts.

Further details concerning the issue, including subscription periods and any directed recipients, will be released in a subsequent announcement. CLS has previously conducted several studies and clinical trials related to its laser therapy methods for treating various medical conditions.

The company has not provided additional information on the specific projects for which the raised funds will be allocated. Further details are expected to be released soon.